• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[勘误] miR-200b/c靶向RhoE的表达并抑制非小细胞肺癌细胞的增殖和侵袭。

[Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells.

作者信息

Tang Qiulin, Li Mingxing, Chen Liang, Bi Feng, Xia Hongwei

机构信息

Laboratory of Molecular Target Therapy in Oncology, West China Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.

出版信息

Int J Oncol. 2022 Dec;61(6). doi: 10.3892/ijo.2022.5432. Epub 2022 Oct 5.

DOI:10.3892/ijo.2022.5432
PMID:36196896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9581111/
Abstract

Subsequently to the publication of the above article, an interested reader drew to the authors' attention that the miR‑200c and Si‑RhoE data panels in Fig. 5B on p. 1739 appeared to contain an overlap of the data, such that the data would have been derived from the same original source where the different panels were intended to show the results from differently performed experiments. The authors have re‑examined their data, and realize that these data panels were inadvertently selected incorrectly; specifically, the data panel showing the results of the migration activities of A549 following transfection with Si‑RhoE in Fig. 5B was incorporated incorrectly during the process of assembling this figure, and this panel contained the overlap with the miR‑200c group. The revised version of Fig. 5, showing all the correct data for Fig. 5B, is presented on the next page. The authors confirm that the errors made in the presentation of Fig. 5 did not adversely affect the conclusions reported in this paper, and they are grateful to the Editor of for granting them this opportunity to publish a Corrigendum. All the authors agree to the publication of this Corrigendum, and they also apologize to the readership for any inconvenience caused. [International Journal of Oncology 53: 1732‑1742, 2018; DOI: 10.3892/ijo.2018.4493].

摘要

在上述文章发表之后,一位感兴趣的读者提请作者注意,第1739页图5B中的miR-200c和Si-RhoE数据图似乎包含重叠数据,以至于这些数据本应来自同一原始来源,而不同的数据图旨在展示不同实验的结果。作者重新检查了他们的数据,意识到这些数据图在无意中被错误选择;具体而言,图5B中显示用Si-RhoE转染后A549迁移活性结果的数据图在组装该图的过程中被错误纳入,并且该数据图与miR-200c组存在重叠。下一页展示了图5的修订版,其中显示了图5B的所有正确数据。作者确认图5呈现中的错误并未对本文所报告的结论产生不利影响,并且他们感谢《国际肿瘤学杂志》编辑给予他们发布勘误的机会。所有作者均同意发布此勘误,并且他们也就所造成的任何不便向读者致歉。[《国际肿瘤学杂志》53: 1732 - 1742, 2018; DOI: 10.3892/ijo.2018.4493]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d68/9581111/12979a14c55a/IJO-61-6-05432-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d68/9581111/12979a14c55a/IJO-61-6-05432-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d68/9581111/12979a14c55a/IJO-61-6-05432-g00.jpg

相似文献

1
[Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells.[勘误] miR-200b/c靶向RhoE的表达并抑制非小细胞肺癌细胞的增殖和侵袭。
Int J Oncol. 2022 Dec;61(6). doi: 10.3892/ijo.2022.5432. Epub 2022 Oct 5.
2
[Corrigendum] SB‑T‑121205, a next‑generation taxane, enhances apoptosis and inhibits migration/invasion in MCF‑7/PTX cells.[勘误] SB-T-121205,一种新一代紫杉烷,增强MCF-7/PTX细胞的凋亡并抑制其迁移/侵袭。
Int J Oncol. 2023 Jan;62(1). doi: 10.3892/ijo.2022.5463. Epub 2022 Dec 9.
3
[Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.[勘误] S100A9通过激活丝裂原活化蛋白激酶(MAPK)信号通路促进HepG2肝癌细胞的增殖和侵袭。
Int J Oncol. 2023 Apr;62(4). doi: 10.3892/ijo.2023.5494. Epub 2023 Mar 3.
4
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.[勘误] 腺病毒中性内肽酶基因递送联合紫杉醇治疗前列腺癌
Int J Oncol. 2024 Nov;65(5). doi: 10.3892/ijo.2024.5694. Epub 2024 Sep 20.
5
[Corrigendum] Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma.[勘误] 长链非编码RNA EGOT作为肾细胞癌肿瘤抑制因子的鉴定
Mol Med Rep. 2024 May;29(5). doi: 10.3892/mmr.2024.13194. Epub 2024 Mar 8.
6
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.[勘误] miR-382通过调控卵巢癌中的上皮-间质转化靶向ROR1来抑制迁移和侵袭。
Int J Oncol. 2024 Nov;65(5). doi: 10.3892/ijo.2024.5698. Epub 2024 Sep 27.
7
[Corrigedum] miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.[勘误] miR-185通过靶向SOX9和调节Wnt信号通路抑制非小细胞肺癌细胞的增殖和侵袭。
Mol Med Rep. 2023 May;27(5). doi: 10.3892/mmr.2023.12984. Epub 2023 Mar 24.
8
[Corrigendum] MicroRNA‑378 enhances migration and invasion in cervical cancer by directly targeting autophagy‑related protein 12.[勘误] 微小RNA-378通过直接靶向自噬相关蛋白12增强宫颈癌的迁移和侵袭能力。
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13366. Epub 2024 Oct 18.
9
[Corrigendum] Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β‑catenin pathway.[勘误] 异硫氰酸苄酯通过调控Wnt/β-连环蛋白信号通路抑制小鼠乳腺癌的发展和转移。
Mol Med Rep. 2022 Oct;26(4). doi: 10.3892/mmr.2022.12823. Epub 2022 Aug 10.
10
[Corrigendum] The tetraspanin CD151‑ARSA mutant inhibits angiogenesis via the YRSL sequence.[勘误] 四跨膜蛋白CD151-ARSA突变体通过YRSL序列抑制血管生成。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13069. Epub 2023 Aug 18.